# Iron Sleep Quality Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/iron-sleep-quality-randomized-trial-evidence-review
Category: evidence-review
Summary: Iron Sleep Quality Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are sys
Last reviewed: 2026-07-04
Reviewed by: Migaku Evidence Review
# Iron Sleep Quality Randomized Trial: What the Evidence Says

## Quick Answer

Iron Sleep Quality Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Efficacy and safety of pharmacological treatments for restless legs syndrome in hemodialysis patients: a systematic review and meta-analysis | systematic review | 1 | 2026-05-20 | 10.3389/fneur.2026.1790771 |
| Treatment of restless legs syndrome by acupuncture combined with medicine based on pathophysiological mechanism | narrative review | 3 | 2026-05-20 | 10.3389/fmed.2026.1785644 |

## What The Sources Report

- Insomnia, daytime sleepiness, mood changes, decreased adherence to treatment and increased cardiovascular risk through increased sympathetic activity have been reported to be linked with RLS severe form. [Zhang Juntao (2026); evidence level 1]
- Nevertheless, there is a lack of consistent evidence and safety concerns that make them not popular first-line treatment options. [Zhang Juntao (2026); evidence level 1]
- Recent investigations in this field have improved our mechanistic understanding on RLS, with evidence implicating dopaminergic dysfunction, brain iron deficiency, and additional signaling pathways that may affect sensory symptoms and motor hyperexcitability. [Liu Rujia (2026); evidence level 3]
- In addition, research on human genetics has advanced rapidly, with the current largest genome-wide meta-analyses now showing a far larger set of risk loci than previously recognized (including > 100 loci), enabling the identification of significant pathways and risk prediction. [Liu Rujia (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For iron sleep quality randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Zhang Juntao (2026). Efficacy and safety of pharmacological treatments for restless legs syndrome in hemodialysis patients: a systematic review and meta-analysis. DOI: 10.3389/fneur.2026.1790771. PMCID: PMC13230204. PMID: 42246040. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13230204/
- Liu Rujia (2026). Treatment of restless legs syndrome by acupuncture combined with medicine based on pathophysiological mechanism. DOI: 10.3389/fmed.2026.1785644. PMCID: PMC13231477. PMID: 42245937. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13231477/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.